Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agentsMulticenter Study Published on 2023-04-012023-06-01 Journal: Scandinavian journal of gastroenterology [Category] 두창, 수두, 홍역, [키워드] immunosuppressive therapy Inflammatory bowel disease measles mumps rubella varicella. [DOI] 10.1080/00365521.2022.2132831 PMC 바로가기 [Article Type] Multicenter Study
Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agentsMulticenter Study Published on 2023-04-012023-06-01 Journal: Scandinavian journal of gastroenterology [Category] 두창, 수두, 홍역, [키워드] immunosuppressive therapy Inflammatory bowel disease measles mumps rubella varicella. [DOI] 10.1080/00365521.2022.2132831 PMC 바로가기 [Article Type] Multicenter Study
COVID-19 and Inflammatory Bowel DiseaseReview Published on 2023-03-012023-07-11 Journal: Gastroenterol Clin North Am : book_id PMC인데 pubmed로 기재 [Category] COVID19(2023년), [키워드] COVID vaccination COVID-19 Crohn disease Immunosuppression Inflammatory bowel disease Long COVID SARS-CoV-2 ulcerative colitis. [DOI] 10.1016/j.gtc.2022.10.005 PMC 바로가기 [Article Type] Review
Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel diseaseReview Published on 2023-03-012023-06-01 Journal: Alimentary pharmacology & therapeutics [Category] 두창, 수두, 홍역, [키워드] herpes zoster Infection Inflammatory bowel disease RCT comparison Safety. [DOI] 10.1111/apt.17379 PMC 바로가기 [Article Type] Review
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemicArticle Published on 2023-02-012023-07-10 Journal: Gut [Category] COVID19(2023년), [키워드] Biological COVID-19 Immunosuppression Inflammatory bowel disease infliximab vaccination vedolizumab. [DOI] 10.1136/gutjnl-2022-327570 PMC 바로가기
Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel diseaseObservational Study Published on 2023-01-012023-07-09 Journal: Gastroenterología y hepatología [Category] COVID19(2023년), [키워드] Biologicals Biológicos COVID-19 Enfermedad inflamatoria intestinal Inflammatory bowel disease SARS-CoV-2 vaccine Vacuna infección SARS-CoV-2. [DOI] 10.1016/j.gastrohep.2022.05.006 PMC 바로가기 [Article Type] Observational Study
SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII projectArticle Published on 2022-12-012023-07-06 Journal: Gastroenterología y hepatología [Category] COVID19(2023년), [키워드] acceptance Aceptación Enfermedad inflamatoria intestinal Hesitance Inflammatory bowel disease Rechazo SARS-CoV-2 vaccination Vacuna. [DOI] 10.1016/j.gastrohep.2021.08.004 PMC 바로가기
COVID-19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposalArticle Published on 2022-12-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] abdominal pain ACE2 acute respiratory syndrome addition association Autoimmune bowel Care caused coronavirus coronavirus disease COVID-19 COVID-19 epidemic diarrhea disease downregulated enzyme Epidemic etiology exacerbate expressed feasibility Genetic IBD IL-17 Imbalance immune activation immunosuppressive drug increase induce Infection Inflammatory Inflammatory bowel disease inflammatory bowel disease. inflammatory disease Inflammatory response intestinal intestinal inflammation intestine lung mechanism nonspecific overlapping pathway Patient patients Pneumonia progression protective factor receptor Research respiratory inflammation risk risk of COVID-19 SARS-CoV-2 SARS-COV-2 infection Symptom systemic symptom the cytokine storm the SARS-CoV-2 Treatment upregulated vaccination [DOI] 10.1002/jmv.28067 PMC 바로가기
Inflammatory bowel disease patient concerns and experiences on transition to home-based infusions during the COVID-19 pandemicArticle Published on 2022-12-012022-11-15 Journal: Research in social & administrative pharmacy : RSA [Category] 진단, [키워드] adverse event age analyzed approach biologics bowel Care category CDC Characteristics collected conducted COVID-19 COVID-19 pandemic COVID-19 transmission disease Factor Guidance Inflammatory bowel disease Infusions. initial iterative one patient outcome pandemic participant Patient performed persistence positive resolved social distancing transitioned [DOI] 10.1016/j.sapharm.2022.06.009 PMC 바로가기
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyArticle Published on 2022-11-012022-11-15 Journal: The Lancet. Gastroenterology & Hepatology [Category] SARS, 진단, [키워드] adjusted age All participant anti-SARS-CoV-2 anti-TNF antibody Antibody binding antibody concentration Antibody concentrations approved available data boost booster case-control study combination therapy Concentration control group COVID-19 COVID-19 vaccine Diagnosis disease dose Evidence first dose geometric mean geometric mean ratio group groups had no healthy control healthy individuals heterologous vaccine homologous IBD Immunosuppressed immunosuppressed patient immunosuppressive Immunosuppressive treatment Infection Inflammatory bowel disease jak inhibitors multicentre multivariable nine no significant difference Older Older age participant Patient patients treated Pfizer Primary outcome receiving Receptor binding domain recipient recruited reduced regimen response S1 RBD SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 vaccination significantly significantly lower Support T-cell Response T-cell responses the healthy therapy Tofacitinib Treatment ulcerative colitis Vaccine vaccine dose vaccine doses vaccine-induced antibody response VIP were measured [DOI] 10.1016/S2468-1253(22)00274-6 PMC 바로가기